Article
Pentraxin-3 is a PI3K signaling target that promotes stem cell–like traits in basal-like breast cancers
21 Feb 2017
Abstract excerpt
expression is greater in tumor samples from patients with BLBC and that it is prognostic of poor patient survival. Our results thus reveal PTX3 as a newly identified PI3K-regulated biomarker and a potential therapeutic target in BLBC.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
